Results 191 to 200 of about 349,023 (332)
Recent Developments in Nanoparticle‐Hydrogel Hybrid Materials for Controlled Release
This review highlights recent advances in nanoparticle–hydrogel hybrid materials for controlled drug delivery. It explores diverse nanocarrier–hydrogel combinations, drug loading strategies, release mechanisms, and stimuli‐responsive behaviors. Emphasis is placed on the molecular interactions driving hybrid material performance, offering insights into ...
Yiping Fan+8 more
wiley +1 more source
Naturally derived biomembrane nanostructures by mimicking evolutionarily optimized biological architectures could effectively suppress tumor growth and have emerged as a compelling strategy in translational biomedicine. This review provides a systematic overview of rational design and underlying antitumor therapeutic mechanisms of mammalian cells ...
Xiaodan Wei+10 more
wiley +1 more source
Chromosomal aberrations in germ cells of male mice immunised with attenuated viral vaccines (human)
L. Venkateswar Rao, H. Polasa
openalex +1 more source
Mechanisms of cytokine synergy essential for vaccine protection against viral challenge [PDF]
Jeffrey D. Ahlers+3 more
openalex +1 more source
Lyophilization is a key process used in the production of biotherapeutic products. This article reviews and discusses the application of HSI on lyophilization, and the strategies that use the resulting data to build models. It is intended to provide guidance and insights for non‐specialist researchers and engineers into leveraging HSI and the data ...
Huiwen Yu+5 more
wiley +1 more source
Self‐amplifying (saRNA), linear (linRNA), and circular (circRNA) mRNAs are compared under standardized conditions using lipid nanoparticles (LNPs) and pABOL polymer. saRNA achieved superior expression, while linRNA and circRNA performance varied based on untranslated region elements and delivery method.
Irafasha C. Casmil+12 more
wiley +1 more source
Early type I IFN blockade improves the efficacy of viral vaccines. [PDF]
Palacio N+6 more
europepmc +1 more source